Joseph McCracken, Director at Nexvet Biopharma, holds 250.84K shares in Savara (Ticker: SVRA), holds 0.00 shares in Lumos Pharma (Ticker: LUMO), holds 6.20K shares in Nexvet Biopharma (Ticker: NVET).

See the Hottest Stocks Based on Insider Trading >

Joseph McCracken
Nexvet Biopharma (NVET)
Director

Ranked #53,150 out of 100,285 Corporate Insiders

Profitable Transactions

2 out of 6 Profitable Transactions

Average Return

-1.50%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

SVRA

A breakdown of Joseph McCracken's holdings

See the Top Stocks by Insiders

Insider Roles

Savara
(SVRA)

Director

Roles that Joseph McCracken holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Savara
(SVRA)

Rating:Informative Buy

Date:Jun 09, 2017 - Jun 09, 2018

Return:+85.20%

The most profitable trade made by Joseph McCracken

See the Latest Stocks Traded by Insiders

Joseph McCracken's Trading History

NVET

Nexvet Biopharma

Aug 02, 2017

―

Uninformative Sell

110.21K

$41.66K

SVRA

Savara

Dec 16, 2024

Director

Uninformative Buy

―

$734.95K

KIN

Kindred Biosciences

―

LUMO

Lumos Pharma

Dec 13, 2024

―

Uninformative Sell

―

$0.00

List of latest transactions for each holding click on a transaction to see Joseph McCracken's performance on stock

See All Insider Trading from Today

Joseph McCracken insider profile FAQ

What is the percentage of profitable transactions made by Joseph McCracken?

The percentage of profitable transactions made by Joseph McCracken is 33%.

What is the average return per transaction made by Joseph McCracken?

The average return per transaction made by Joseph McCracken is -1.50%.

What stocks does Joseph McCracken hold?

Joseph McCracken holds: NVET, SVRA, KIN, LUMO stocks.

What was Joseph McCracken’s latest transaction?

Joseph McCracken latest transaction was an Uninformative Buy of ―.

What was Joseph McCracken's most profitable transaction?

Joseph McCracken’s most profitable transaction was an Informative Buy of SVRA stock on June 9, 2017. The return on the trade was 85.20%.

What is Joseph McCracken's role in Nexvet Biopharma?

Joseph McCracken's role in Nexvet Biopharma is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Joseph McCracken Insider Profile

Joseph McCracken Nexvet Biopharma (NVET)Director